Psoralen photobiology and photochemotherapy: 50 years of science and medicine
Tóm tắt
Từ khóa
Tài liệu tham khảo
Song, 1979, Photochemistry and photobiology of psoralens, Photochem Photobiol, 29, 1177, 10.1111/j.1751-1097.1979.tb07838.x
Gasparro, 1994
Cimino, 1985, Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry, Ann Rev Biochem, 54, 1151, 10.1146/annurev.bi.54.070185.005443
Yun, 1992, A novel photoadduct of 4,5′,8-trimethylpsoralen and adenosine, Photochem Photobiol, 55, 457, 10.1111/j.1751-1097.1992.tb04261.x
Frederiksen, 1979, Binding of 4′-aminomethyl-4,5′,8-trimethylpsoralen to DNA, RNA and protein in HeLa cells and Drosophila cells, Biochem Biophys Acta, 563, 343
Tessmann, 1985, Photochemistry of the furan-side 8-methoxypsoralen-thymidine monoadduct inside the DNA helix. Conversion to diadduct and to pyrone-side monoadduct, Biochemistry, 24, 1669, 10.1021/bi00328a015
Chen, 1994, Photosensitized cross-linking and cleavage of pBR322 and M13 DNA: comparison of 4,4′,-trimethylangelicin and 3-carbethoxypsoralen, J Photochem Photobiol B: Biol, 22, 51, 10.1016/1011-1344(93)06953-Z
Bordin, 1994, 4,6,4′-Trimethylangelicin induces interstrand cross-links in mammalian cell DNA, J Photochem Photobiol B: Biol, 26, 197, 10.1016/1011-1344(94)07040-7
Gasparro, 1995, Novel approaches to tailoring psoralen use to phototherapeutic need, Curr Opin Dermatol, 2, 167
Olack, 1993, Improved high-performance liquid chromatographic analysis of 8-methoxypsoralen monoadducts and cross-links in polynucleotide, DNA, and cellular systems: analysis of split-dose protocols, Photochem Photobiol, 57, 941, 10.1111/j.1751-1097.1993.tb02953.x
Gasparro, 1993, Visible excitation of 8-MOP: HPLC quantitation of monoadducts and cross-links, Photochem Photobiol, 57, 1007, 10.1111/j.1751-1097.1993.tb02963.x
Midden, 1988, Chemical mechanisms of the bioeffects of furocoumarins the role of reactions with proteins, lipids and other cellular constituents in CRC book, 2
Beijersbergen van Henegouwen, 1989, Method for the determination of the in vivo irreversible binding of 8-methoxypsoralen (8-MOP) to epidermal lipids, proteins and DNA/RNA of rats after PUVA treatment, J Photochem Photobiol B: Biol, 3, 631, 10.1016/1011-1344(89)80086-7
Schmitt, 1995, Psoralen-protein photochemistry—a forgotten field, J Photochem Photobiol B: Biol, 27, 101, 10.1016/1011-1344(94)07101-S
Sastry, 1997, Isolation and partial characterization of a novel psoralen–tyrosine photoconjugate from a photoreaction of psoralen with a natural protein, Photochem Photobiol, 65, 937, 10.1111/j.1751-1097.1997.tb07951.x
Kittler, 1984, Photoreactions of furocoumarins with membrane constituents. Results with fatty acids and artificial bilayers, Stud Biophys, 101, 69
Specht, 1988, A new biological target of furocoumarins: photochemical formation of covalent adducts with unsaturated fatty acids, Photochem Photobiol, 47, 537, 10.1111/j.1751-1097.1988.tb08841.x
Caffieri, 1987, Formation of photoadducts between unsaturated fatty acids and furocoumarins, Med Biol Environ, 15, 11
Dall'Acqua, 1994, Unsaturated fatty acids psoralen cycloadducts play a role of second messenger as diacylglycerol, Photochem Photobiol, 59, 55
Mantulin, 1973, Excited states of skin-sensitizing coumarins and psoralens. Spectroscopic studies, J Am Chem Soc, 95, 5122, 10.1021/ja00797a004
Vallat, 1994, PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy, J Exp Med, 180, 283, 10.1084/jem.180.1.283
Johnson, 1996, PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes, Photochem Photobiol, 63, 566, 10.1111/j.1751-1097.1996.tb05657.x
Godar, 1999, Light and death: photon-induced apoptosis, J Invest Dermatol Symp Proc, 5, 000
Bernstein, 1995, Ultraviolet radiation activates the human elastin promoter in transgenic mice: a novel in vivo and in vitro model of cutaneous photoaging, J Invest Dermatol, 105, 269, 10.1111/1523-1747.ep12318419
Bernstein, 1996, 8-Methoxypsoralen and ultraviolet radiation A activates human elastin promoter-direct evidence for gene induction in vitro and in vivo evidence for gene induction, Photochem Photobiol, 64, 369, 10.1111/j.1751-1097.1996.tb02473.x
Zmudzka, 1993, Activation of the human immunodeficiency virus promoter by UVA radiation in combination with psoralens and angelicins, Photochem Photobiol, 58, 226, 10.1111/j.1751-1097.1993.tb09553.x
Moor, 1995, Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results, J Photochem Photobiol B: Biol, 29, 193, 10.1016/1011-1344(95)07143-P
Schmitt, 1995, Increased surface expression of class I MHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength ultraviolet radiation, Tissue Antigens, 46, 45, 10.1111/j.1399-0039.1995.tb02474.x
Felli, 1995, Treatment with 8-methoxypsoralen (8-MOP)/UVA increases MHC class II expression on human monocytes, J Invest Dermatol, 104, 647
Lambert, 1989, Enhancement of major histocompatibility class I protein synthesis by DNA damage in cultured human fibroblasts and keratinocytes, Mol Cell Biol, 9, 847, 10.1128/MCB.9.2.847
Chen, 1986, Gamma-interferon and 5-azacytidine cause transcriptional elevation of class I major histocompatibility complex gene expression in K562 leukemia cells in the absence of differentiation, Mol Cell Biol, 6, 1698, 10.1128/MCB.6.5.1698
Hauser, 1993, Radiation-enhanced expression of major histocompatibility complex class I antigen in H-2Db in B16 melanoma cells, Cancer Res, 53, 1952
Kerbel, 1984, Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment, J Cell Phys, 3, 87, 10.1002/jcp.1041210411
Gilmour, 1993, The effect of UV therapy on immune function in patients with psoriasis, Br J Dermatol, 129, 28, 10.1111/j.1365-2133.1993.tb03307.x
Aberer, 1986, Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1 positive dendritic epidermal cells, J Immunol, 136, 1210, 10.4049/jimmunol.136.4.1210
Fivenson, 1994, Quantitative PCR analysis of Th1 cytokines in HUT 78 cells after exposure to PUVA in vitro, J Invest Dermatol, 102, 585A
Saed, 1994, Quantitation of interferon gamma mRNA levels in psoralen/UVA-treated HUT-78 cells by competitive PCR, Biochem Biophys Res Commun, 203, 935, 10.1006/bbrc.1994.2272
Vowels, 1992, Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis, J Invest Dermatol, 98, 686, 10.1111/1523-1747.ep12499907
McCaffrey, 1994, Comparison of effects of direct-acting DNA methylating and ethylating agents on inducible genes in vivo, Environ Mol Mutagen, 23, 164, 10.1002/em.2850230303
Zhan, 1993, Induction of cellular p53 activity by DNA-damaging agents and growth arrest, Mol Cell Biol, 13, 4242, 10.1128/MCB.13.7.4242
Houbiers, 1993, In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53, Eur J Immunol, 23, 2072, 10.1002/eji.1830230905
Devary, 1993, NF-κB activation by ultraviolet light not dependent on a nuclear signal, Science, 261, 1442, 10.1126/science.8367725
Legrandpoels, 1995, Transcription factor NF-kappa b is activated by photosensitization generating oxidative DNA damages, J Biol Chem, 270, 6925, 10.1074/jbc.270.12.6925
Maschek, 1989, Altered regulation of MHC class I genes in different tumor lines is reflected by distinct sets of DNASE I hypersensitive sites, EMBO J, 8, 2297, 10.1002/j.1460-2075.1989.tb08356.x
Leiden, 1994, Transcriptional regulation of T-cells during T-cell development, Curr Opin Immunol, 6, 231, 10.1016/0952-7915(94)90096-5
Väkevä, 1998, Oral psoralen and ultraviolet A (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer, J Natl Cancer Inst, 90, 1278, 10.1093/jnci/90.17.1278
Petersheim, 1991, Cytogenetic effects during extracorporeal photopheresis treatment of two patients with cutaneous T cell lymphoma, Arch Dermatol Res, 283, 81, 10.1007/BF00371613
Chiou, 1995, Mutagenicity and specific mutation spectrum induced by 8-methoxypsoralen plus a low dose of UVA in the hprt gene in diploid human fibroblasts, Carcinogenesis, 16, 1357, 10.1093/carcin/16.6.1357
Gunther, 1995, Mutagenesis by 8-methoxypsoralen and 5-methylangelicin photoadducts in mouse fibroblasts: mutations at cross-linkable sites induced by monoadducts as well as cross-links, Cancer Res, 55, 1283
Bredberg, 1987, Psoralen adducts in a shuttle vector plasmid propagated in primate cells: high mutagenicity of DNA cross-links, Carcinogenesis, 8, 1923, 10.1093/carcin/8.12.1923
Sage, 1991, Damage distribution and mutation spectrum: the case of 8-methoxypsoralen and UVA in mammalian cells, Mut Res, 263, 217, 10.1016/0165-7992(91)90004-N
Gasparro, 1998, Psoralen photochemotherapy, clinical efficacy and photomutagenicity: the role of molecular epidemiology in minimizing risks, Environ Mol Mutagen, 31, 105, 10.1002/(SICI)1098-2280(1998)31:2<105::AID-EM2>3.0.CO;2-L
Nataraj, 1996, Signature p53 mutations at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers, Proc Natl Acad Sci USA, 93, 7961, 10.1073/pnas.93.15.7961
Nataraj, 1997, p53 mutations in squamous cell carcinomas from psoriasis patients treated with psoralen+UVA (PUVA): Relative frequency of PUVA- versus UV-signature mutations, J Invest Dermatol, 109, 238, 10.1111/1523-1747.ep12319764
Wang, 1997, An unexpected spectrum of p53 mutations from squamous cell carcinomas in patients treated with PUVA, Photochem Photobiol, 66, 294, 10.1111/j.1751-1097.1997.tb08658.x
Sagher, 1983, Insertion of nucleotides opposite apurine/apyrmidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides, Biochemistry, 22, 4518, 10.1021/bi00288a026
Greenblatt, 1994, Mutations in p53 tumor suppression gene: clues to cancer etiology and molecular pathogenesis, Cancer Res, 54, 4855
Kripke, 1984, Effects of methoxsalen plus near-ultraviolet radiation or mid-ultraviolet radiation on immunologic mechanisms, Natl Cancer Inst Monogr, 66, 247
Ren, 1997, Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin, Am J Pathol, 150, 1791
Jonason, 1996, Frequent clones of p53-mutated keratinocytes in normal human skin, Proc Natl Acad Sci USA, 93, 14025, 10.1073/pnas.93.24.14025
McGregor, 1997, p53 Mutations implicate sunlight in post-transplant skin cancer irrespective of human papilloma virus status, Oncogene, 15, 1737, 10.1038/sj.onc.1201339
Bennett, 1997, p53 mutations in squamous cell carcinomas from renal transplant recipients, Biochem Soc Trans, 25, 342, 10.1042/bst0250342
Van de Kerkhof, 1997, Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclopsorin treatment: response to long-term acitretin maintenance, Br J Dermatol, 136, 275, 10.1046/j.1365-2133.1997.d01-1187.x
Servilla, 1987, Ability of cyclosporin to promote growth of transplanted ultraviolet-induced tumors in mice, Transplant, 44, 291, 10.1097/00007890-198708000-00022
Weinstock, 1995, Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy, Arch Dermatol, 131, 701, 10.1001/archderm.131.6.701
Rübben, 1996, Demonstration of human papillomavirus type 16-related DNA and absence of detectable p53 gene mutations in widespread cutaneous squamous cell carcinoma after oral psoralen with UV-A treatment, Arch Dermatol, 132, 1257, 10.1001/archderm.132.10.1257